Clinical trial
Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar…
NCT00181922 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181922 |
|---|---|
| Title | Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder |
| Official title | Open-Label Study of Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Spectrum Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder, Mania |
| Intervention type | Drug |
| Interventions | ziprasidone (Geodon) |
| Enrollment | 20 |
| Start date | Mar 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Oct 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: